Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 3, 2009 - Issue 1
Journal homepage
74
Views
2
CrossRef citations to date
0
Altmetric
Review

Procalcitonin as a biomarker of acute lower respiratory tract infections

Tomasz Wróblewski Oddział Nefrologii i Chorób Wewnetrznych, Szpital Powiatowy w Chrzanowie, ul. Topolowa 16, PL 32-500 Chrzanów, Poland +48 32 624 7326, +48 32 624 7777; +48 32 623 9428; [email protected]; Oddział Kliniczny Chorób Wewnetrznych w Tychach, Wydział Opieki Zdrowotnej, Slaski Uniwersytet Medyczny w Katowicach/Wojewódzki Szpital Specjalistyczny Nr 1 w Tychach, Poland
, MD &
Czesław Marcisz Oddział Kliniczny Chorób Wewnetrznych w Tychach, Wydział Opieki Zdrowotnej, Slaski Uniwersytet Medyczny w Katowicach/Wojewódzki Szpital Specjalistyczny Nr 1 w Tychach, Poland
, MD PhD
Pages 67-79 | Published online: 23 Dec 2008

Bibliography

  • Meisner M. Procalcitonin (PCT) – a new, innovative infection parameter. Biochemical and clinical aspects. Stuttgart, New York: Thieme; 2000. ISBN 3-13-105503-0
  • Christ-Crain M, Müller B. Procalcitonin in bacterial infections – hype, hope, more or less? Swiss Med Wkly 2005;135:451-60
  • Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8
  • Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002;323:17-29
  • Müller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001;131:595-602
  • Maruna P, Nedělníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49(Suppl 1):S57-61
  • Morgenthaler NG, Struck J, Fischer-Schulz C, et al. Detection of procalcitonin (PCT) in healthy controls and patients with local infections by a sensitive ILMA. Clin Lab 2002;48(5-6):263-70
  • Nishikura T. Procalcitonin (PCT) production in a thyroidectomized patients. Intensive Care Med 1999;25:1031
  • Weglohner W, Struck J, Fischer-Schulz C, et al. Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides 2001;22(12):2099-103
  • Wrenger S, Kähne T. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). FEBS Lett 2000;466(1):155-9
  • Oberhoffer M, Stonans I. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro J Lab Med 1999;134(1):49-55
  • Russwurm S, Stonans I. Procalcitonin and CGRP-1 mRNA expression in various human tissues. Shock 2001;16(2):109-12
  • Morgenthaler NG, Struck J, Chancerelle Y, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res 2003;35:290-5
  • Müller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404
  • Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003;144:5578-84
  • Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004;32:1715-21
  • Monneret G, Laroche B, Bienvenu J. Procalcitonin is not produced by circulating blood cells. Infection 1999;27:34-5
  • Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8
  • Wiedermann FJ, Kaneider N, Egger P, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002;30:1112-7
  • Monneret G, Arpin M, Venet F, et al. Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils. Intensive Care Med 2003;29:923-8
  • Hoffmann G, Totzke G, Seibel M, et al. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med 2001;29:112-6
  • Hoffmann G, Czechowski M, Schloesser M, Schobersberger W. Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002;30:2091-5
  • Nylen ES, Whang KT, Snider RH, et al. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998;26:1001-6
  • Martinez JM, Wagner KE, Snider RH, et al. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surg Infect (Larchmt) 2001;2:193-202
  • Wagner KE, Martinez JM, Vath SD, et al. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 2002;30:2313-21
  • Becker KL, Nylen ES, Snider RH, et al. Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res 2003;9:367-74
  • Christ-Crain M, Müller B. Diagnostic and prognostic value of hormokines as biomarkers in severe infections. In: Vincent JL, editor, Yearbook of Intensive Care and Emergency Medicine. Berlin, Heidelberg, New York: Springer-Verlag; 2007. ISBN 978-3-540-49432-4
  • Christ-Crain M, Morgenthaler NG, Struck J, et al. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005;9:R816-24
  • Christ-Crain M, Morgenthaler NG, Stolz D, et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care 2006;10:R96-103
  • Zeni F, Viallon A, Assicot M, et al. Procalcitonin serum concentrations and severity of sepsis. Clin Intensive Care 1994;5(Suppl 2):89-98
  • Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999;3:45-55
  • Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 2000;28:68-73
  • Brunkhorst FM, Al-Nawas B, Krummenauer F, et al. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002;8:93-100
  • Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596-602
  • Müller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28(4):977-83
  • Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402
  • Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 2000;26(Suppl 2):S148-52
  • American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74
  • Pirozynski M, editor. Zakazenia układu oddechowego [Infections of the respiratory tract]. Warszawa: Osrodek Informacji Naukowej OINPHARMA; 2007. ISBN 978-83-919134-4-4
  • Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54
  • Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10
  • Dremsizov T, Clermont G, Kellum JA, et al. Severe sepsis in community-acquired pneumonia: When does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 2006;129(4):968-78
  • Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis. Arch Intern Med 2007;167(15):1655-63
  • Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080-4
  • Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54
  • Halm EA, Teirstein AS. Clinical practice. Management of community-acquired pneumonia. N Engl J Med 2002;347:2039-45
  • Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33
  • Pneumonia Guidelines Committee of BTS Standards of Care Committee. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001;56(Suppl IV):iv1-iv64
  • Stocks NP, McElroy H, Sayer GP, Duszynski K. Acute bronchitis in Australian general practice. A prescription too far? Aust Fam Physician 2004;33:91-3
  • Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the UK: implications for developing management guidelines. Respir Med 1997;91:427-34
  • Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000;133:981-91
  • Woodhead M, Blasi F, Ewig S, et al. ERS Task Force in collaboration with ESCMID. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138-80
  • File TM Jr, Mandell LA. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 2003;36:396-8
  • Wise R, Hart T, Cars O, et al. Antimicrobial resistance. BMJ 1998;317:609-10
  • Wenzel RP, Wong MT. Managing antibiotic use – impact of infection control. Clin Infect Dis 1999;28:1126-7
  • Guillemot D, Courvalin P. Better control of antibiotic resistance. Clin Infect Dis 2001;33:542-7
  • Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87
  • Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999;43:459-65
  • Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999;281:1512-9
  • Melbye H, Berdal BP, Straume B, et al. Pneumonia: a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice. Scand J Infect Dis 1992;24:647-55
  • Wipf JE, Lipsky BA, Hirschmann JV, et al. Diagnosing pneumonia by physical examination: relevant or relic? Arch Intern Med 1999;159:1082-7
  • Melbye H. Community pneumonia: more help is needed to diagnose and assess severity. Br J Gen Pract 2002;52:886-8
  • Gramm HJ, Dollinger P, Beier W. Procalcitonin – ein neuer Marker der inflammatorischen Wirtsantwort. Longitudinalstudien bei Patienten mit Sepsis und Peritonitis. Chir Gastroenterol 1995;11(Suppl 2):51-4
  • Nylen ES, Snider RH Jr, Thompson KA, et al. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 1996;312:12-18
  • de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997;25:607-13
  • Martinot M, Hansmann Y, De Martino S, et al. La procalcitonine dans les pyelonephrites et les pneumopathies communautaires aigues de l'adulte [Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults]. Presse Med 2001;30:1091-6
  • Polzin A, Pletz M, Erbes R, et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003;21:939-43
  • Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community-acquired pneumonia. Arch Dis Child 2001;84:332-6
  • Prat C, Domínguez J, Rodrigo C, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 2003;22:963-7
  • Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001;17:623-7
  • Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: A negative result in primary healthcare settings. Pediatr Pulmonol 2003;35:56-61
  • Toikka P, Irjala K, Juvén T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19:598-602
  • Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-7
  • Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: A randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007;131:9-19
  • Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Respir Crit Care Med 2006;174:84-93
  • Briel M, Christ-Crain M, Young J, et al. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]. BMC Fam Pract 2005;6:34
  • Briel M, Schuetz P, Müller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008;168:2000-7
  • Nobre V, Harbarth S, Graf JD, et al. Shorter treatment duration and shorter stay in ICU after PCT-guided antibiotic therapy. Am J Respir Crit Care Med 2008;177:498-505
  • Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50
  • Masiá M, Gutiérrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the Patients Outcome Research Team Pneumonia Severity Index. Chest 2005;128:2223-9
  • Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin In iatrogenic sepsis. Intensive Care Med 1998;24:888-9
  • Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005;171:48-53
  • Boussekey N, Leroy O, Alfandari S, et al. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006;32(3):469-72
  • Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31(2):349-55
  • Sachse C, Dressler F, Henkel E. Increased serum procalcitonin in newborn infants without infection. Clin Chem 1998;44:1343-4
  • Chiesa C, Panero A, Rossi N, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998;26:664-72
  • Wanner GA, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000;28:950-7
  • Stiletto RJ, Baacke M, Gotzen L, et al. Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion. Crit Care Med 2001;29;1690-3
  • Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998;24:680-4
  • Nylen ES, Jeng J, Jordan MH, et al. Late pulmonary sequela following burns: persistence of hyperprocalcitonemia using a 1–57 amino acid N-terminal flanking peptide assay. Respir Med 1995;89:41-6
  • Nylen ES, Al Arifi A, Becker KL, et al. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997;25:1362-5
  • Eberhard OK, Langefeld I, Kuse ER, et al. Procalcitonin in the early phase after renal transplantation – will it add to diagnostic accuracy? Clin Transplant 1998;12:206-11
  • Gerard Y, Hober D, Petitjean S, et al. High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 1995;23:310-1
  • Christofilopoulou S, Charvalos E. Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 2002;13(8):493-5
  • Beaune G, Bienvenu F. Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis. Infection 1998;26(3):168-9
  • Davis TME, Assicot M. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994;88:670-1
  • Uzzan B, Izri A. Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study. Travel Med Infect Dis 2006;4(2):77-80
  • Soderquist B, Jones I, Fredlund H, Vikerfors T. Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand J Infect Dis 1998;30:591-6
  • Van Dissel JT. Procalcitonin: what should be its role in the clinical management of febrile patients admitted to the hospital? Clin Infect Dis 2003;36:824-5; author reply 826-827
  • Debard AL, Vautrin C, Pariset C, et al. High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever. Clin Infect Dis 2003;36:825-6; author reply 826-827
  • Ruokonen E, Nousiainen T. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999;18(4):283-5
  • Svaldi M, Hirber J. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001;115(1):53-7
  • Jensen JU, Løken J, Mohr T. Procalcitonin and Survival Study (PASS) Group. Procalcitonin: Nice to know, need to know, or needs further research? In: Vincent JL, editor, Yearbook of Intensive Care and Emergency Medicine. Berlin, Heidelberg, New York: Springer-Verlag; 2007. ISBN 978-3-540-49432-4
  • Price CP. Point of care testing. BMJ 2001;322:1285-8
  • Meisner M, Brunkhorst FM, Reith HB, et al. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 2000;38:989-95
  • Kordek A, Giedrys-Kalemba S, Pawlus B, et al. Porównanie ilosciowej (LUMItest) i półilos ´ciowej (Brahms PCT-Q) metody oznaczania stezenia prokalcytoniny w surowicy krwi noworodków [Comparison of quantitative (LUMItest) and semi-quantitative (Brahms PCT-Q) tests for PCT concentration measurements in the newborns' blood]. Adv Clin Exp Med 2004;13(6):945-8
  • Charles PGP, Grayson ML. Point-of-care tests for lower respiratory tract infections. MJA 2007;187:36-9
  • Dwyer DE, Sintchenko V. Point-of-care testing for community-acquired pneumonia: do we have all the answers? MJA 2007;187:40-2
  • Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.